Abstract:Glycogen storage disorders (GSDs) are a group of inherited metabolic disorders characterized by defects in enzymes involved in glycogen metabolism. Deficiencies in enzymes responsible for glycogen breakdown and synthesis can impair mitochondrial function. For instance, in GSD type II (Pompe disease), acid alpha-glucosidase deficiency leads to lysosomal glycogen accumulation, which secondarily impacts mitochondrial function through dysfunctional mitophagy, which disrupts mitochondrial quality control, generating oxidative stress. In GSD type III (Cori disease), the lack of the debranching enzyme causes glycogen accumulation and affects mitochondrial dynamics and biogenesis by disrupting the integrity of muscle fibers. Malfunctional glycogen metabolism can disrupt various cascades, thus causing mitochondrial and cell metabolic dysfunction through various mechanisms. These dysfunctions include altered mitochondrial morphology, impaired oxidative phosphorylation, increased production of reactive oxygen species (ROS), and defective mitophagy. The oxidative burden typical of GSDs compromises mitochondrial integrity and exacerbates the metabolic derangements observed in GSDs. The intertwining of mitochondrial dysfunction and GSDs underscores the complexity of these disorders and has significant clinical implications. GSD patients often present with multisystem manifestations, including hepatomegaly, hypoglycemia, and muscle weakness, which can be exacerbated by mitochondrial impairment. Moreover, mitochondrial dysfunction may contribute to the progression of GSD-related complications, such as cardiomyopathy and neurocognitive deficits. Targeting mitochondrial dysfunction thus represents a promising therapeutic avenue in GSDs. Potential strategies include antioxidants to mitigate oxidative stress, compounds that enhance mitochondrial biogenesis, and gene therapy to correct the underlying mitochondrial enzyme deficiencies. Mitochondrial dysfunction plays a critical role in the pathophysiology of GSDs. Recognizing and addressing this aspect can lead to more comprehensive and effective treatments, improving the quality of life of GSD patients. This review aims to elaborate on the intricate relationship between mitochondrial dysfunction and various types of GSDs. The review presents challenges and treatment options for several GSDs.

Glycogen metabolism and structure: A review

Biochemical and clinical aspects of glycogen storage diseases

Normal and abnormal glycogen structure - A review

Glycogen metabolism and glycogen storage disorders

From Prokaryotes to Eukaryotes: Insights Into the Molecular Structure of Glycogen Particles

The importance of glycogen molecular structure for blood glucose control

Glycogen Storage Diseases: A Brief Review and Update on Clinical Features, Genetic Abnormalities, Pathologic Features, and Treatment

The Molecular Background of Glycogen Metabolism Disorders

Beyond Energy Storage: Roles Of Glycogen Metabolism In Health And Disease

Recent developments in our understanding of glycogen structure

Glycogen storage diseases: New perspectives

Glycogen storage diseases: An update

Pathobiology of the Hepatic Glycogen Storage Diseases

Gene Therapy for Glycogen Storage Diseases

Myocardial glycogen dynamics: new perspectives on disease mechanisms.

Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Recent Progress in the Structure of Glycogen Serving As a Durable Energy Reserve in Bacteria

Molecular structure of glycogen in diabetic liver

Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs)

Glycogen Storage Disease: Clinical, Biochemical, and Molecular Heterogeneity